The rising burden of allergy is most evident in infancy, indicating the importance of early exposures. Reduced vitamin D status in pregnancy has been associated with atopy and respiratory outcomes, but there is less information on other early allergic outcomes.
Allergic diseases are now the most common chronic disorders of childhood, with a pressing need to define the causal pathways and better prevention strategies. In particular, the rates of food allergy and eczema 1 have continued to increase dramatically in children as part of what appears to be a "second wave" of the allergy epidemic. 2 Progressively earlier presentations with disease clearly implicate early environmental influences such as exposures in pregnancy. 2 Although this is likely to be multifactorial, there has been growing speculation that vitamin D insufficiency in pregnancy may have adverse consequences for early immune development of the fetus. 3 Previous studies provide a persuasive basis for the hypothesis that vitamin D may protect against allergic disease. 4 Reduced maternal dietary vitamin D intake in pregnancy has been reported as a risk factor for respiratory conditions such as wheezing, asthma, and allergic rhinitis 5, 6 ; however, these studies were largely based on questionnairederived data rather than biological measures. Other studies have examined "season of birth" as a surrogate marker of vitamin D status through sunlight exposure and found significantly higher rates of food allergy in children born in autumn and winter (compared with spring and summer), providing indirect evidence that seasonal variations in sunlight exposure may make an important contribution to early disease risk. 7 In older children, there is also evidence of lower serum 25-hydroxyvitamin D 3 (25 [OH]D 3 ) associated with allergen sensitization, eczema severity, and asthma. [8] [9] [10] Here, we have examined cord blood (CB) serum 25(OH)D 3 levels to reflect both dietary and nondietary derived vitamin D in pregnancy. To our knowledge, this is the first study to examine CB 25(OH) D 3 levels as an indicator of fetal exposure to vitamin D in relation to infant eczema outcomes. Our prospective cohort study with well-defined allergic outcomes, documented maternal dietary and supplement intakes in pregnancy, and CB serum samples provided an ideal opportunity to examine this question in addition to other early allergic outcomes.
METHODS

Study Design and Subjects
The mother-infant pairs included in this study were derived from a larger (n = 669) prospective birth cohort recruited between 2002 and 2009 for the investigation of dietary exposures in relation to infant allergy outcomes. Only nonsmoking mothers with healthy, uncomplicated term pregnancies were recruited. The population used for this study was selected on the basis of (1) $2 frozen CB serum samples in storage (317/669), (2) allergic outcomes assessed at 12 months of age (259/ 317), and (3) at least 1 parent with a history of allergic disease (eczema, asthma, or hay fever) (231/259). The latter criterion was included because infants with a family history of atopy have a greater risk of developing allergic disease (50%-80%) than those with no family history (20%), 11 providing greater statistical power, and results from this population are the most relevant and transferable to allergy prevention strategies. The cohort was recruited in Perth, Western Australia, as approved by the Princess Margaret Hospital Ethics Committee. Mothers provided written, informed consent.
Assessment of Antenatal Vitamin D Intake
In the last trimester of pregnancy, mothers completed a validated semiquantitative food frequency questionnaire developed and analyzed by the Commonwealth Scientific and Industrial Research Organization in Adelaide, Australia. 12 This recorded the frequency of consumption of 212 individual foods, mixed foods, and beverages from which vitamin D intake in IUs could be calculated. Energy intake cutoffs were applied to identify unreliable records. 13 In addition to food and drink items, details of all dietary supplements taken in the last trimester of pregnancy (including doses, brands, and frequency of consumption) were collected. Reported supplement intake was converted into daily vitamin D intake (IU) by using composition information provided by the manufacturers.
Collection and Analysis of Umbilical CB Samples for 25(OH)D 3 Concentration
At delivery, blood was collected from the umbilical cord or placental vein, and an aliquot (7-9 mL) transferred to a serum clot activator tube, which was kept out of light and processed within 8 hours. Aliquots of serum were stored at 280°C and transported in dry ice for analysis by RMIT Drug Discovery Technologies (Melbourne, Australia) by using liquid chromatography-tandem mass spectrometry (Applied Biosystems 4000 Q Trap and Agilent LC-MS/ MS). The lower limit of quantification was 4.69 ng/mL for 25(OH)D 3 , and the intra-assay precision had a coefficient of variation of ,5%.
For categorical analysis by CB 25(OH)D 3 concentrations we used cutoffs of ,50 nmol/L, 50 to 74.99 nmol/L, and $75 nmol/L, as described in the literature. 14 Although similar cutoffs have been used by others in relation to CB concentrations 15, 16 there is evidence to suggest that neonatal 25(OH)D 3 concentrations are generally lower than CB concentrations. 17 We therefore used these values as categorical descriptors of vitamin D status rather than diagnostic criteria.
ARTICLE
Assessment of Allergic Status
The primary outcome measures in the infants at 12 months of age were eczema and allergen sensitization. Infants were defined as having eczema if they had a doctor' s diagnosis of eczema, or evidence of typical skin lesions. The extent and severity of the eczema was determined by the standardized SCORing Atopic Dermatitis (SCORAD) severity index, 18 measured on the day and as mother-reported worst ever episode. An objective SCORAD of ,15 was classified as mild, 15 to 40 as moderate, and .40 as severe. Allergen sensitization was assessed by use of the skin prick test by using common allergen extracts (whole egg, cow' s milk, peanut, house dust mite [Dermatophagoides pteronyssinus], cat, rye grass pollen, mold mix; Hollister-Stier Laboratories, Spokane, WA). A wheal diameter of $3 mm was considered positive. The secondary outcome was immunoglobulin E (IgE)-mediated food allergy, which was defined as a history of immediate symptoms (typically within 60 minutes) after contact with and/or ingestion of food and a positive skin prick test to the implicated food. Information on respiratory symptoms (recurrent wheeze) and physician-diagnosed asthma were also collected, but these were not analyzed because of the limitations in diagnosis at this age.
Statistical Analysis
In this high-risk population, we estimated that .40% of infants would have vitamin D deficiency 19, 20 and ∼40% infants at age 1 who would have either food allergy, eczema, or atopy (defined by skin prick test). Based on these assumptions, a sample size of 230 was estimated to detect an odds ratio (OR) of 2.5 with a power .0.8 in the vitamin D deficiency group, at a significance of.05. The distribution of CB 25(OH)D 3 concentration represented approximate normality after adjusting an outlying value. Because all results between the natural and adjusted data set were unaffected, parametric tests were performed by using adjusted data. Objective SCORAD data and maternal vitamin D intake from diet or supplements were not normally distributed. Means were compared by using the Mann-Whitney U test. Differences in CB 25(OH)D 3 concentration by month of birth were analyzed by 1-way analysis of variance and Bonferroni post hoc test. Logistic regression was used to estimate the risk of allergic outcomes by CB 25(OH)D 3 status while adjusting for confounders. We included recognized confounders of vitamin D status and allergic disease in our analyses, specifically season of birth, pets in the home, infant gender, maternal age, maternal education, and ethnicity. All statistics were performed by using SPSS software (version 19 for IBM, SPSS Inc, Chicago, IL).
RESULTS
Population Characteristics
The characteristics of the study population (n = 231) are shown in Table 1 . The maternal population was predominately of white ethnicity and tertiary educated. A history of maternal allergic disease was reported for 86.1% of the infants, and 51.9% of the infants had both parents with a history of allergic disease. 
Season of Birth Effect
Concentrations of CB 25(OH)D 3 varied significantly by month of birth, with the Australian summer/autumn months of January, February, and March representing significantly higher levels than the winter/spring months of August, September, and October (Fig 2) . Summer births showed a significantly greater percentage of CB 25(OH)D 3 concentrations $75 nmol/L in comparison with spring births (43.9% and 12.1%, respectively) in addition to a smaller proportion with concentrations ,50 nmol/L (12.2% and 65.5%, respectively, P , .001) (Fig 3) .
Maternal Characteristics
Although the seasons of birth were not significantly different for Asian and white participants, CB 25(OH)D 3 concentrations were significantly higher for those of white (59.39 [23. 77] nmol/L, n = 184) in comparison with Asian ethnicity (37.01 [18. 36] nmol/L, n = 9) (P = .006).
There was no relationship between CB 25(OH)D 3 concentrations and maternal age controlling for season of birth, nor was maternal education a significant predictor of vitamin D status.
Maternal Vitamin D Intake From Diet and Supplements in Pregnancy
The reported intakes of vitamin D from background dietary sources suggest that 85.1% of women in the main cohort had dietary vitamin D intakes that were less than the recommended dietary intake during pregnancy of 200 IU/day. 21 Antenatal supplement use was reported by 212/231 (91.8%) mothers, but information on brand, type, and frequency was only provided by 146/231 (63.2%). Vitamin D intake from diet and supplements is presented in Table 1 .
The Relationship Between Maternal Intake and CB 25(OH)D 3 Concentrations
Maternal intake of vitamin D from supplements was significantly correlated with CB vitamin D status (r = 0.244, P = .003), whereas the relationship between CB levels and background dietary intake was not significant (r = 20.105, P = .173).
Association Between CB 25(OH)D 3 and Allergic Outcomes in Infants
Eczema
Consistent with other similar populations at high risk of allergic disease, eczema was the most common expression of the allergic phenotype, affecting 34% of the infants in this study 22 ( Table 2 ). CB 25(OH)D 3 concentrations were significantly (P = .018) lower in infants who had developed eczema by 12 months of age (Fig 4) . The risk of eczema declined significantly as CB 25 (OH)D 3 increased, with a 10 nmol/L rise in CB 25(OH)D 3 reducing risk by 13.3% (OR 0.87, 95% confidence interval [CI] 0.77-0.98; P = .020). The association remained significant after adjustment for multiple confounding factors (Table  3) . We found a significant negative doseresponse trend across categories of vitamin D status (OR 0.63, 95% CI 0.44-0.90; P = .013) and an OR 2.66 for infants with CB 25(OH)D 3 ,50 nmol/L compared with the reference group of $75 nmol/L (95% CI 1.24-5.72; P = .012) (Fig  5) . Mean CB 25(OH)D 3 concentration was not significantly different between IgE-and non-IgE-associated eczema.
Objective SCORAD measures were conducted on 65/78 infants with eczema (severity categories described in Table 2 ). The median (interquartile range) SCORAD score on the day of assessment and worst ever were 7.8 14 and 18.1, 13 respectively. We found no correlation between CB 25(OH)D 3 concentration and SCORAD on the day of examination (r = 20.022, P = .862) or worst ever (r = 0.092, P = .467). There was no difference in SCORAD score between IgE-or nonIgE-associated eczema.
Allergen Sensitization
Skin prick tests were conducted on 217/ 231 infants. Of these 21.2% were found to be sensitized to at least 1 allergen (see Table 2 ). CB 25(OH)D 3 concentration was not significantly associated with an increased risk for allergen sensitization (OR 1.0, 95% CI 0.9-1.01; P = .642).
IgE-Mediated Food Allergy
IgE-mediated food was present in 24/ 231 infants. Egg was the most common allergy affecting 6.5% of infants in this study, followed by milk and peanut allergy affecting 1.7% and 1.3%, respectively. Four of the 231 infants (1.7%) displayed allergy to .1 food. The risk of developing IgE-mediated food allergy was not related to CB 25(OH)D 3 (OR 1.00, 95% CI 0.99-1.02; P = .584).
Recurrent Wheeze
There was no significant difference in mean CB 25 
Association Between Maternal Vitamin D Intake and Allergic Outcomes in Infants
Maternal vitamin D intake from supplements was not different for infants with or without eczema (P = .571), allergen sensitization (P = .563), or IgE-mediated food allergy (P = .341). 17 ). We did find marked seasonal variation in CB vitamin D status; summer births displayed significantly greater concentrations.
Consistent with our findings, Miyake et al 23 found an association between lower maternal vitamin D consumption in pregnancy and increased risk of eczema in infants. These observations are also in keeping with a series of pregnancy studies that found that lower vitamin D intakes were associated with increased risk of other potential (respiratory-based) indicators of an allergic phenotype including recurrent wheeze, 5,24,25 subsequent asthma, and allergic rhinitis. 6 In addition, several studies using indirect measures of nondietary vitamin D such as season of birth (surrogate for sunlight exposure) found that birth in
FIGURE 2
Mean and SE of CB 25(OH)D 3 concentration by month of birth. January (*) is significantly greater than August and September; February (#) and March (^) are significantly greater than August, September, and October. P , .05 is considered significant.
FIGURE 3
Change in the proportion of infants in each of the 3 status categories across seasons. The proportions of CB 25(OH)D 3 concentrations ,50 nmol/L and $75 nmol/L are significantly different between summer/ autumn and winter/spring (P , .001).
winter months was associated with higher rates of subsequent eczema 26 and food allergy. 7 Although these studies support a protective role for improving status, they cannot exclude confounding effects of other seasonal 29 This active form facilitates the production of the antimicrobial peptide cathelicidin. 29 Notably, in subjects with atopic dermatitis, 25(OH)D 3 levels are positively correlated with serum cathelicidin and its production in both keratinocytes and neutrophils. 30 It is possible that insufficient vitamin D levels contribute to the impaired barrier function characteristic in eczema, 31 because diminished CYP27B1 and reduced production of 1,25(OH) 2 D 3 result in hyperproliferation of the basal layers and disrupted barrier integrity, 32 coupled with impaired antimicrobial activity. 30 Cathelicidin levels in lesional skin of established eczema increase significantly in response to oral 25(OH)D 3 supplementation, 29 supporting a role of vitamin D in promoting antimicrobial functions and barrier integrity. As in the study by Kanda et al, 30 we did not find that serum vitamin D levels predicted the severity of disease (SCORAD).
A limitation of this study is that the highrisk nature of the population may not be reflective of other populations. In the absence of serial blood collections throughout pregnancy and infancy, it is 
CONCLUSIONS
The findings of this study provide new evidence that reduced fetal exposure to vitamin D increases the risk of eczema in infants by 12 months of age. This adds to the growing body of evidence that vitamin D status is important for many aspects of health and that interventions to improve vitamin D status in pregnancy may be an important part of preventive strategies. This will be more definitively assessed through randomized controlled trials to assess the effects of maternal and/or infant vitamin D supplementation on immune development and clinical outcomes in childhood.
ACKNOWLEDGMENTSFIGURE 5
OR for development of allergic outcomes in infants with CB 25(OH)D 3 ,50 nmol/L, compared with reference category $75 nmol/L. 
